Cristiano Guedes Bezerra

Cristiano Guedes Bezerra

Auto-generated profile, based on publicly available information

Cristiano Guedes Bezerra

Hospital Aliança Rede D’Or, Brasil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2025 in New England Journal of Medicine
Verified
Journal Article
Closed access
PGPatricia O. Guimarães
Patricia O. Guimarães
MFMarcelo Franken
Marcelo Franken
CTCaio A.M. Tavares
Caio A.M. Tavares
MAMurillo O. Antunes
Murillo O. Antunes
FSFabio S. Silveira
Fabio S. Silveira
PLPedro A. Lemos
Pedro A. Lemos
Whether potent P2Y12 inhibitor monotherapy without aspirin initiated shortly after successful percutaneous coronary intervention (PCI) is effective and safe for patients with acute coronary syndromes is unclear. We conducted a multicenter, open-label, randomized trial in Brazil involving patients with acute coronary syndromes who had undergone successful PCI. Patients were assigned in a 1:1 ratio within the first 4 days of hospitalization to stop treatment with aspirin and receive potent P2Y12 inhibitor monotherapy (ticagrelor or prasugrel) or to receive dual antiplatelet therapy (aspirin and a potent P2Y12 inhibitor) for 12 months. The two ranked primary outcomes, assessed through 12 months, were a composite of death from any cause, myocardial infarction, stroke, or urgent target-vessel revascularization (tested for noninferiority, with a noninferiority margin of 2.5 percentage points) and major or clinically relevant nonmajor bleeding (tested for superiority). A total of 3410 patients were included in the intention-to-treat population (1712 in the monotherapy group and 1698 in the dual antiplatelet therapy group). At 12 months, death from any cause, myocardial infarction, stroke, or urgent revascularization had occurred in 119 patients (Kaplan-Meier estimate, 7.0%) in the monotherapy group and in 93 patients (Kaplan-Meier estimate, 5.5%) in the dual antiplatelet therapy group (absolute risk difference, 1.47 percentage points; 95% confidence interval [CI], -0.16 to 3.10; P = 0.11 for noninferiority). Major or clinically relevant nonmajor bleeding had occurred in 33 patients (Kaplan-Meier estimate, 2.0%) in the monotherapy group and in 82 patients (Kaplan-Meier estimate, 4.9%) in the dual antiplatelet therapy group (absolute risk difference, -2.97 percentage points; 95% CI, -4.20 to -1.73). Stent thrombosis occurred in 12 patients in the monotherapy group and in 4 in the dual antiplatelet therapy group. Among patients who had undergone successful PCI for acute coronary syndromes, potent P2Y12 inhibitor monotherapy was not found to be noninferior to dual antiplatelet therapy with respect to a composite of death or ischemic events at 12 months. (Funded by the Brazilian Ministry of Health; NEO-MINDSET ClinicalTrials.gov number, NCT04360720.).

22 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PBP. J. Blanco
P. J. Blanco
CBC. A. Bulant
C. A. Bulant
LML. O. Müller
L. O. Müller
GTG. D. Maso Talou
G. D. Maso Talou
CBC. Guedes Bezerra
C. Guedes Bezerra
RFR. A. Feijóo
R. A. Feijóo
In this work we propose to validate the predictive capabilities of one-dimensional (1D) blood flow models with full three-dimensional (3D) models in the context of patient-specific coronary hemodynamics in hyperemic conditions. Such conditions mimic the state of coronary circulation during the acquisition of the Fractional Flow Reserve (FFR) index. Demonstrating that 1D models accurately reproduce FFR estimates obtained with 3D models has implications in the approach to computationally estimate FFR. To this end, a sample of 20 patients was employed from which 29 3D geometries of arterial trees were constructed, 9 obtained from coronary computed tomography angiography (CCTA) and 20 from intra-vascular ultrasound (IVUS). For each 3D arterial model, a 1D counterpart was generated. The same outflow and inlet pressure boundary conditions were applied to both (3D and 1D) models. In the 1D setting, pressure losses at stenoses and bifurcations were accounted for through specific lumped models. Comparisons between 1D models (FFR 1D ) and 3D models (FFR 3D ) were performed in terms of predicted FFR value. Compared to FFR 3D , FFR 1D resulted with a difference of 0.00 ± 0.03 and overall predictive capability AUC, Acc, Spe, Sen, PPV and NPV of 0.97, 0.98, 0.90, 0.99, 0.82, and 0.99, with an FFR threshold of 0.8. We conclude that inexpensive FFR 1D simulations can be reliably used as a surrogate of demanding FFR 3D computations.

12 September 2018 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
CBCristiano G. Bezerra
Cristiano G. Bezerra
AHAlexandre Hideo‐Kajita
Alexandre Hideo‐Kajita
CBCarlos A. Bulant
Carlos A. Bulant
GMGonzalo D. Maso‐Talou
Gonzalo D. Maso‐Talou
JMJose Mariani
Jose Mariani
PLPedro A. Lemos
Pedro A. Lemos

1 January 2017 in Journal of Biomechanics
Verified
Journal Article
Closed access
CBC.A. Bulant
C.A. Bulant
PBP.J. Blanco
P.J. Blanco
GTG.D. Maso Talou
G.D. Maso Talou
CBC. Guedes Bezerra
C. Guedes Bezerra
PLP.A. Lemos
P.A. Lemos
RFR.A. Feijóo
R.A. Feijóo

24 June 2015 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
GTGonzalo D. Maso Talou
Gonzalo D. Maso Talou
ILIgnacio Larrabide
Ignacio Larrabide
PBPablo J. Blanco
Pablo J. Blanco
CBCristiano Guedes Bezerra
Cristiano Guedes Bezerra
PLPedro A. Lemos
Pedro A. Lemos
RFRaul A. Feijoo
Raul A. Feijoo
Goal: Coronary intravascular ultrasound (IVUS) is a fundamental imaging technique for atherosclerotic plaque assessment. However, volume-based data retrieved from IVUS studies can be misleading due to the artifacts generated by the cardiac motion, hindering diagnostic, and visualization of the vessel condition. Then, we propose an image-based gating method that improves the performance of the preexisting methods, delivering a gating in an appropriate time for clinical practice. Methods: We propose a fully automatic method to synergically integrate motion signals from different gating methods to improve the cardiac phase estimation. Additionally, we present a local extrema identification method that provides a more accurate extraction of a cardiac phase and, also, a scheme for multiple phase extraction mandatory for elastography-type studies. Results: A comparison with three state-of-the-art methods is performed over 61 in-vivo IVUS studies including a wide range of physiological situations. The results show that the proposed strategy offers: 1) a more accurate cardiac phase extraction; 2) a lower frame oversampling and/or omission in the extracted phase data (error of 1.492 ± 0.977 heartbeats per study, mean ± SD); 3) a more accurate and robust heartbeat period detection with a Bland-Altman coefficient of reproducibility (RPC) of 0.23 s, while the second closest method presents an RPC of 0.36 s. Significance: The integration of motion signals performed by our method shown an improvement of the gating accuracy and reliability.

28 January 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
AQAlexandre Quadros
Alexandre Quadros
KBKarlyse C. Belli
Karlyse C. Belli
JPJoão E. T. de Paula
João E. T. de Paula
CCCarlos Campos
Carlos Campos
ASAntonio C. B. da Silva
Antonio C. B. da Silva
LPLucio Padilla
Lucio Padilla